HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingwei Zhang Selected Research

Glioma (Gliomas)

1/2022CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways.
1/2021Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas.
9/2019Understanding the cellular uptake and biodistribution of a dual-targeting carrier based on redox-sensitive hyaluronic acid-ss-curcumin micelles for treating brain glioma.
1/2019Local strategies and delivery systems for the treatment of malignant gliomas.
12/2018Tween 80-modified hyaluronic acid-ss-curcumin micelles for targeting glioma: Synthesis, characterization and their in vitro evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingwei Zhang Research Topics

Disease

43Neoplasms (Cancer)
12/2022 - 03/2009
21Breast Neoplasms (Breast Cancer)
01/2021 - 10/2008
8Inflammation (Inflammations)
01/2022 - 06/2012
6Neoplasm Metastasis (Metastasis)
05/2022 - 10/2008
5Glioma (Gliomas)
01/2022 - 12/2018
4Tuberculosis (Tuberculoses)
11/2021 - 01/2020
4Cerebral Hemorrhage
01/2021 - 04/2017
4Hypoxia (Hypoxemia)
03/2019 - 06/2012
3Colitis
06/2022 - 09/2015
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 12/2019
3Chemical and Drug Induced Liver Injury
06/2021 - 01/2019
3Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 10/2018
3Infections
01/2021 - 01/2012
3Brain Injuries (Brain Injury)
01/2021 - 01/2020
3Drug-Related Side Effects and Adverse Reactions
01/2020 - 01/2018
3Tibial Fractures (Fracture, Tibial)
11/2015 - 08/2014
2Non-alcoholic Fatty Liver Disease
12/2022 - 05/2022
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022 - 09/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 04/2018
2Neuroinflammatory Diseases
11/2021 - 01/2021
2Ulcerative Colitis
06/2021 - 09/2015
2Stroke (Strokes)
01/2021 - 01/2015
2Chronic Disease (Chronic Diseases)
01/2021 - 06/2012
2Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2014
2Acute Kidney Injury (Acute Renal Failure)
07/2020 - 03/2018
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 11/2019
2Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 08/2017
2Lung Neoplasms (Lung Cancer)
04/2019 - 12/2016
2Squamous Cell Carcinoma of Head and Neck
01/2018 - 01/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2017 - 01/2016
2Hematoma
04/2017 - 01/2016
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 10/2015
2Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 10/2015
2Developmental Dysplasia of the Hip
12/2015 - 03/2014
2Stomach Neoplasms (Stomach Cancer)
08/2012 - 06/2010
2Carcinoma (Carcinomatosis)
04/2010 - 12/2004
1Liver Diseases (Liver Disease)
12/2022
1Facies
10/2022
1Hepatitis B
07/2022

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
12/2022 - 06/2010
10Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2004
6Messenger RNA (mRNA)IBA
01/2022 - 10/2008
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 04/2010
6MicroRNAs (MicroRNA)IBA
01/2020 - 08/2012
5Therapeutic UsesIBA
12/2022 - 02/2015
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
5CateninsIBA
01/2021 - 11/2017
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 12/2010
4Particulate MatterIBA
08/2022 - 01/2021
4Long Noncoding RNAIBA
01/2022 - 08/2017
4vasodilator-stimulated phosphoproteinIBA
08/2012 - 10/2008
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2018
3Antitubercular AgentsIBA
11/2021 - 01/2019
3Biological ProductsIBA
06/2021 - 01/2016
3Fluorouracil (Carac)FDA LinkGeneric
04/2021 - 10/2018
3radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA
04/2021 - 01/2014
3PeroxiredoxinsIBA
01/2021 - 01/2020
3Small Interfering RNA (siRNA)IBA
11/2017 - 10/2008
2NitrogenIBA
10/2022 - 11/2019
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2CytokinesIBA
01/2022 - 06/2012
2Interleukin-4 (Interleukin 4)IBA
01/2022 - 11/2020
2IronIBA
10/2021 - 04/2017
2Oxygen (Dioxygen)IBA
10/2021 - 01/2017
2Liposomes (Liposome)IBA
08/2021 - 12/2016
2EnzymesIBA
06/2021 - 03/2014
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2021 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2021 - 03/2019
2Protein Kinases (Protein Kinase)IBA
01/2021 - 01/2020
2AntigensIBA
01/2021 - 07/2019
2AntibodiesIBA
01/2021 - 07/2019
2Plant Preparations (Preparation, Plant)IBA
09/2020 - 01/2016
2CreatinineIBA
07/2020 - 11/2019
2Urea (Carbamide)FDA LinkGeneric
07/2020 - 11/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2017
2Hyaluronic Acid (Hyaluronan)IBA
09/2019 - 12/2018
2MicellesIBA
09/2019 - 12/2018
2Polysorbates (PSML)FDA Link
09/2019 - 12/2018
2CurcuminIBA
09/2019 - 12/2018
2SincalideFDA Link
01/2019 - 01/2018
223- O- (1,4'- bipiperidine- 1- carbonyl)betulinic acidIBA
12/2015 - 04/2010
223-hydroxybetulinic acidIBA
12/2015 - 04/2010
1Fatty Acids (Saturated Fatty Acids)IBA
12/2022
1Vitamin A (Retinol)FDA LinkGeneric
12/2022
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2022
1Heavy MetalsIBA
08/2022
1Natural Gas (Gas, Natural)IBA
08/2022
1Coal (Coals)IBA
08/2022
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
08/2022
1MetalsIBA
07/2022
1Tenofovir (Viread)FDA Link
07/2022

Therapy/Procedure

16Therapeutics
05/2022 - 03/2014
6Drug Therapy (Chemotherapy)
08/2021 - 10/2018
5External Fixators
11/2015 - 07/2012
4Immunotherapy
12/2022 - 08/2021
4Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022 - 03/2014
3Radiotherapy
01/2019 - 01/2018
2Injections
01/2021 - 09/2018
2Peritoneal Dialysis
01/2020 - 11/2019
2Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2016 - 06/2010